257 related articles for article (PubMed ID: 28161890)
1. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
[TBL] [Abstract][Full Text] [Related]
2. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
3. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
[TBL] [Abstract][Full Text] [Related]
4. Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.
Fischer G; Pan B; Vilceanu D; Hogan QH; Yu H
Gene Ther; 2014 Jan; 21(1):44-51. PubMed ID: 24152582
[TBL] [Abstract][Full Text] [Related]
5. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
Piekarz AD; Due MR; Khanna M; Wang B; Ripsch MS; Wang R; Meroueh SO; Vasko MR; White FA; Khanna R
Mol Pain; 2012 Jul; 8():54. PubMed ID: 22828369
[TBL] [Abstract][Full Text] [Related]
6. AAV-encoded Ca
Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
[TBL] [Abstract][Full Text] [Related]
7. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.
Wilson SM; Brittain JM; Piekarz AD; Ballard CJ; Ripsch MS; Cummins TR; Hurley JH; Khanna M; Hammes NM; Samuels BC; White FA; Khanna R
Channels (Austin); 2011; 5(5):449-56. PubMed ID: 21829088
[TBL] [Abstract][Full Text] [Related]
8. A peptidomimetic modulator of the Ca
Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
[TBL] [Abstract][Full Text] [Related]
10. Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.
Brustovetsky T; Pellman JJ; Yang XF; Khanna R; Brustovetsky N
J Biol Chem; 2014 Mar; 289(11):7470-82. PubMed ID: 24474686
[TBL] [Abstract][Full Text] [Related]
11. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
[TBL] [Abstract][Full Text] [Related]
12. The Natural Flavonoid Naringenin Elicits Analgesia through Inhibition of NaV1.8 Voltage-Gated Sodium Channels.
Zhou Y; Cai S; Moutal A; Yu J; Gómez K; Madura CL; Shan Z; Pham NYN; Serafini MJ; Dorame A; Scott DD; François-Moutal L; Perez-Miller S; Patek M; Khanna M; Khanna R
ACS Chem Neurosci; 2019 Dec; 10(12):4834-4846. PubMed ID: 31697467
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the analgesic peptide DrTx(1-42) revealing a functional role of the amino-terminal turn.
Li P; Zhu S
PLoS One; 2012; 7(2):e31830. PubMed ID: 22355398
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin prevents synaptogenesis between sensory and spinal cord neurons induced by thrombospondin-4 acting on pre-synaptic Ca
Yu YP; Gong N; Kweon TD; Vo B; Luo ZD
Br J Pharmacol; 2018 Jun; 175(12):2348-2361. PubMed ID: 29338087
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury.
Yao Y; Ji Y; Ren J; Liu H; Khanna R; Sun L
Mol Brain; 2021 Aug; 14(1):123. PubMed ID: 34362425
[TBL] [Abstract][Full Text] [Related]
16. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Feldman P; Khanna R
Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
[TBL] [Abstract][Full Text] [Related]
17. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.
Brittain JM; Duarte DB; Wilson SM; Zhu W; Ballard C; Johnson PL; Liu N; Xiong W; Ripsch MS; Wang Y; Fehrenbacher JC; Fitz SD; Khanna M; Park CK; Schmutzler BS; Cheon BM; Due MR; Brustovetsky T; Ashpole NM; Hudmon A; Meroueh SO; Hingtgen CM; Brustovetsky N; Ji RR; Hurley JH; Jin X; Shekhar A; Xu XM; Oxford GS; Vasko MR; White FA; Khanna R
Nat Med; 2011 Jun; 17(7):822-9. PubMed ID: 21642979
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.
Wilson SM; Schmutzler BS; Brittain JM; Dustrude ET; Ripsch MS; Pellman JJ; Yeum TS; Hurley JH; Hingtgen CM; White FA; Khanna R
J Biol Chem; 2012 Oct; 287(42):35065-35077. PubMed ID: 22891239
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2).
Brittain JM; Chen L; Wilson SM; Brustovetsky T; Gao X; Ashpole NM; Molosh AI; You H; Hudmon A; Shekhar A; White FA; Zamponi GW; Brustovetsky N; Chen J; Khanna R
J Biol Chem; 2011 Oct; 286(43):37778-92. PubMed ID: 21832084
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
